EP2931313
Efnablöndulausnir tilbúinna AND-IL-23P19 mótefna
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.12.2013EP published:
8.5.2019EP application number:
13863590.9
EP translation filed:
27.6.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
8.12.2033Expiry date:
8.12.2026Next due date:
31.12.2026
Title:
SOLUTION FORMULATIONS OF ENGINEERED ANTI-IL-23P19 ANTIBODIES
Timeline
Today
9.12.2013EP application
8.5.2019EP Publication
27.6.2019Translation submitted
15.7.2019Registration published
8.12.2026Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Ave., P.O. Box 2000, Rahway, NJ 07065, US
Inventor
Name:
KASHI, Ramesh, S.Address:
Kenilworth, NJ, US
Name:
BADKAR, AniketAddress:
Portage, MI, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261737035 PDate:
13.12.2012Country:
US
Classification
Categories:
C07K 16/24, A61K 39/395, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.12.2019
Expires: 8.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.11.2020
Expires: 8.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 1.12.2021
Expires: 8.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 21.11.2022
Expires: 8.12.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 15.12.2023
Expires: 8.12.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.11.2024
Expires: 8.12.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.12.2025
Expires: 8.12.2026
Payer: Árnason Faktor ehf.